The Use of Viral Peptides as a Quality Control for ELISPOT Assays in HIV-1 Vaccine Trials in Kenya
Date
2004Author
Farah, B M
Ogola, S
Indangasi, J
Oyaro, M
Anzala, O
Omosa-Manyonyi, G
Jaoko, W
Gillmour, J
Bwayo, J
1Kavi, Nairobi, Kenya; 2Iavi, New York, United State
Type
PresentationLanguage
enMetadata
Show full item recordAbstract
Abstract no. A10065"
Citation
B M Farah , , et al. The use of viral peptides as a quality control for ELISPOT assays in HIV-1 vaccine trials in Kenya . CD Only: The XV International AIDS Conference: Abstract no. A10065"Publisher
University of Nairobi, College of Health Sciences,